About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3687751
Allelic
Composition
Btkxid/Btkxid
Genetic
Background
involves: CBA/HN * DBA/2N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Btkxid mutation (2 available); any Btk mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• spleens from females have ~40% immunoglobulin-bearing cells compared to ~50% in controls (J:81429)
• Background Sensitivity: numbers are greater in female mutants on CBA * C57BL/6 background (40%) than females on CBA/HN background (22%) (J:81429)
• spleens from females have ~40% immunoglobulin-bearing cells compared to ~50% in controls (J:81429)
• Background Sensitivity: numbers are greater in female mutants on CBA * C57BL/6 background (40%) than females on CBA/HN background (22%) (J:81429)
• number of nucleated spleen cells (~90 x 106/spleen) is significantly lower than in controls (~120 x 106/spleen) (J:81429)
• Background Sensitivity: females on the CBA * DBA/2J (~90 x 106/spleen) have significantly more nucleated spleen cells CBA/HN females (~60 x 106/spleen) (J:81429)
• number of nucleated spleen cells (~90 x 106/spleen) is significantly lower than in controls (~120 x 106/spleen) (J:81429)
• Background Sensitivity: females on the CBA * DBA/2J (~90 x 106/spleen) have significantly more nucleated spleen cells CBA/HN females (~60 x 106/spleen) (J:81429)
• spleen cells from unsensitized females cause 3-fold higher chromium release from H-2b antibody treated EL-4 tumor cells than splenocytes from males (J:81429)
• spleen cells from unsensitized females cause 3-fold higher chromium release from H-2b antibody treated EL-4 tumor cells than splenocytes from males (J:81429)
• B cells show response to LPS and poly I:C similar to wild-type cells (J:81429)
• Background Sensitivity: proliferative response in B cells from females is much higher than in cells from female mutants on CBA/HN background (J:81429)
• B cells show response to LPS and poly I:C similar to wild-type cells (J:81429)
• Background Sensitivity: proliferative response in B cells from females is much higher than in cells from female mutants on CBA/HN background (J:81429)

immune system
• spleens from females have ~40% immunoglobulin-bearing cells compared to ~50% in controls (J:81429)
• Background Sensitivity: numbers are greater in female mutants on CBA * C57BL/6 background (40%) than females on CBA/HN background (22%) (J:81429)
• spleens from females have ~40% immunoglobulin-bearing cells compared to ~50% in controls (J:81429)
• Background Sensitivity: numbers are greater in female mutants on CBA * C57BL/6 background (40%) than females on CBA/HN background (22%) (J:81429)
• number of nucleated spleen cells (~90 x 106/spleen) is significantly lower than in controls (~120 x 106/spleen) (J:81429)
• Background Sensitivity: females on the CBA * DBA/2J (~90 x 106/spleen) have significantly more nucleated spleen cells CBA/HN females (~60 x 106/spleen) (J:81429)
• number of nucleated spleen cells (~90 x 106/spleen) is significantly lower than in controls (~120 x 106/spleen) (J:81429)
• Background Sensitivity: females on the CBA * DBA/2J (~90 x 106/spleen) have significantly more nucleated spleen cells CBA/HN females (~60 x 106/spleen) (J:81429)
• spleen cells from unsensitized females cause 3-fold higher chromium release from H-2b antibody treated EL-4 tumor cells than splenocytes from males (J:81429)
• spleen cells from unsensitized females cause 3-fold higher chromium release from H-2b antibody treated EL-4 tumor cells than splenocytes from males (J:81429)
• B cells show response to LPS and poly I:C similar to wild-type cells (J:81429)
• Background Sensitivity: proliferative response in B cells from females is much higher than in cells from female mutants on CBA/HN background (J:81429)
• B cells show response to LPS and poly I:C similar to wild-type cells (J:81429)
• Background Sensitivity: proliferative response in B cells from females is much higher than in cells from female mutants on CBA/HN background (J:81429)

Mouse Models of Human Disease
OMIM ID Ref(s)
Agammaglobulinemia, X-Linked; XLA 300755 J:81429


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
01/26/2016
MGI 6.02
The Jackson Laboratory